David Klaum stated, "After recently receiving first approval for Ciclopirox Topical Suspension USP, we are excited to add this important additional first approval and first-to-market to the Ciclopirox line of products, providing the market with another quality option for their topical needs."
As a specialty pharmaceutical manufacturer of topical steroids, antibiotics and antifungal products, as well as ophthalmics, Fougera has received more topical generic FDA approvals than any other company during the past six years. This ability to provide a continuing stream of new products benefits both health care providers seeking multi-source alternatives with the ability to reduce health care costs, and patients whose conditions warrant their application.
Fougera manufactures and distributes a wide range of multi-source topical and ophthalmic pharmaceuticals, in both prescription and over-the-counter dosage forms.
No comments:
Post a Comment